Catalogo dei prodotti della ricerca

GARIBALDI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.846
EU - Europa 1.559
AS - Asia 674
AF - Africa 34
SA - Sud America 18
Totale 5.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.812
IT - Italia 1.001
SG - Singapore 277
IN - India 167
CN - Cina 101
SE - Svezia 73
UA - Ucraina 70
DE - Germania 61
FI - Finlandia 57
ID - Indonesia 44
NL - Olanda 41
GB - Regno Unito 39
FR - Francia 36
BG - Bulgaria 27
CA - Canada 27
IE - Irlanda 24
HK - Hong Kong 22
TG - Togo 22
CH - Svizzera 21
JP - Giappone 20
ES - Italia 18
AT - Austria 11
BE - Belgio 11
RO - Romania 10
VN - Vietnam 8
AL - Albania 7
SC - Seychelles 7
TR - Turchia 7
AR - Argentina 6
GR - Grecia 6
PH - Filippine 6
CZ - Repubblica Ceca 5
LI - Liechtenstein 5
MX - Messico 5
RS - Serbia 5
BR - Brasile 4
LU - Lussemburgo 4
MK - Macedonia 4
PL - Polonia 4
PT - Portogallo 4
BD - Bangladesh 3
CO - Colombia 3
HU - Ungheria 3
PE - Perù 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
IL - Israele 2
IS - Islanda 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
MN - Mongolia 2
PK - Pakistan 2
RU - Federazione Russa 2
TH - Thailandia 2
UG - Uganda 2
EE - Estonia 1
HR - Croazia 1
IR - Iran 1
MU - Mauritius 1
MY - Malesia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 5.131
Salva come PNG Salva come JPEG
Città #
Fairfield 456
Rome 244
Chandler 243
Ashburn 227
Singapore 223
Woodbridge 196
Seattle 174
Houston 165
Wilmington 146
Cambridge 121
Milan 100
San Paolo di Civitate 85
Santa Clara 79
Ann Arbor 75
Princeton 68
Lawrence 59
Dearborn 55
Jakarta 41
Millbury 40
New York 38
Beijing 32
San Diego 31
Helsinki 29
Plano 29
Boston 27
Sofia 27
Andover 24
Dublin 23
Lomé 22
Boardman 21
Hong Kong 21
Fremont 17
Bengaluru 15
Toronto 15
Des Moines 14
Rotterdam 14
Bremen 13
Paris 13
San Mateo 12
Nanjing 11
Naples 11
Florence 10
Taranto 9
Turin 9
Chicago 8
Frankfurt am Main 8
Vienna 8
Bolzano 7
Falkenstein 7
Nice 7
Norwalk 7
Ponzano Veneto 7
Tokyo 7
Brussels 6
Cascina 6
Fasano 6
Ottawa 6
Padova 6
Palermo 6
Barcelona 5
Bari 5
Dallas 5
Hanoi 5
Jacksonville 5
Mahé 5
Mannheim 5
Phoenix 5
Stockholm 5
Bologna 4
Brescia 4
Bühl 4
Falls Church 4
Federal 4
Groningen 4
Guangzhou 4
Hyderabad 4
Kunming 4
Lappeenranta 4
London 4
Los Angeles 4
Manchester 4
Oxford 4
Pesaro 4
Sordio 4
Tirana 4
Trieste 4
Waanrode 4
Bodrum 3
Brent 3
Calcinaia 3
Dhaka 3
Genoa 3
Grosseto 3
Jinan 3
Kyoto 3
Lima region 3
Luxembourg 3
Madrid 3
Mexico City 3
Mezzolombardo 3
Totale 3.546
Salva come PNG Salva come JPEG
Nome #
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 257
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab 169
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study 163
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial 158
Core-rod myopathy due to a novel mutation in BTB/POZ domain of KBTBD13 manifesting as late onset LGMD 152
Eculizumab improves fatigue in refractory generalized myasthenia gravis 132
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 116
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis 105
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 92
Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case–control study 92
LOPED study. looking for an early diagnosis in a late-onset pompe disease high-risk population 90
Creatine kinase and progression rate in amyotrophic lateral sclerosis 89
Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity 88
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 86
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre 85
Nerve high resolution ultrasonography in Tangier disease 85
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 85
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation 84
Novel dominant mutation in BIN1 gene causing mild centronuclear myopathy revealed by myalgias and CK elevation 83
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 83
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study 83
Erectile dysfunction in myotonic dystrophy type 1 (DM1) 79
Erectile dysfunction in Myotonic Dystrophy type 1 (DM1) 78
Dominant BIN1-related centronuclear myopathy (CNM) revealed by lower limb myalgia and moderate CK elevation 77
Dropped-head in recessive oculopharyngeal muscular dystrophy 76
Expanding the spectrum of genes responsible for hereditary motor neuropathies 75
Recessive MYPN mutations cause cap myopathy with occasional nemaline rods 74
Teaching video neuro images. the beevor sign in late-onset pompe disease 73
Muscle MRI in neutral lipid storage disease (NLSD) 70
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 70
Long term follow-up of cerebrovascular abnormalities in late onset pompe disease (LOPD) 67
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy 67
Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients 66
A dangerous food binge. a case report of hypokalemic periodic paralysis and review of current literature 62
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 61
Gender effect on cardiac involvement in myotonic dystrophy type 1 60
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 60
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) 59
Muscle MRI in neutral lipid storage disease (NLSD) 59
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 59
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 58
Tubular aggregate myopathy with miosis caused by a novel mutation in ORAI1 58
Reply to the letter entitled “Predictors of respiratory impairment in patients with myotonic dystrophy type 1” 55
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores 55
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer 55
Intracellular insulin mediated signalling in Myotonic Dystrophy type 1 (DM1) 52
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients 51
Effects of Mexiletine on cardiac parameters, muscle strenght and myotonia in Myotonic Dystrophy 49
Thymomatous myasthenia gravis. novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity 49
A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis 49
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 48
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 47
Immune checkpoint inhibitors (ICIs)-related ocular myositis 47
The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo 45
CORRELATIONS BETWEEN ULTRASOUND CHARACTERISTICS AND NEUROPHYSIOLOGICAL DATA IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING NEUROPATHY (CIDP): A BLINDED CASE-CONTROL STUDY 45
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 43
Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge 43
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases 42
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 40
Effects of Skin Stimulation on Sensory-Motor Networks Excitability: Possible Implications for Physical Training in Amyotrophic Lateral Sclerosis 40
Dusty core disease (DuCD): expanding morphological spectrum of RYR1 recessive myopathies 39
The Silent Period for Small Fiber Sensory Neuropathy Assessment in a Mixed Cohort of Transthyretin-Mediated Amyloidosis 38
Distal upper limb involvement in myasthenia-myositis association 38
Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome 38
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? 37
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study 36
MiR206 and 423‑3p Are Differently Modulated in Fast and Slow‑Progressing Amyotrophic Lateral Sclerosis Patients 36
Lipid Myopathies 36
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy 36
Telemedicine for neuromuscular disorders during the COVID-19 outbreak 34
Childhood-onset dystonia-causing KMT2B variants result in a distinctive genomic hypermethylation profile 34
Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study 32
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) 31
Combined proteomic and lipidomic studies in Pompe disease allow a better disease mechanism understanding 31
Comprehensive cardiovascular management of myotonic dystrophy type 1 patients: a report from the italian neuro-cardiology network 30
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy 30
Metodo di studio della via intracellulare insulino-mediata nella Distrofia Miotonica tipo 1 (DM1) 26
Nefl-Related Charcot-Marie tooth disease due to P440L mutation in two italian families: expanding the phenotype and defining modulating factors 25
Successful treatment with plasmapheresis in a patient with glutamic acid decarboxylase (GAD) antibody positive Stiff-Person syndrome 25
Effects of triheptanoin on mitochondrial respiration and glycolysis in cultured fibroblasts from neutral lipid storage disease type M (NLSD-M) patients 24
Miopatie e malattie della giunzione neuromuscolare 24
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 23
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors 22
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2) 22
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 21
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature 20
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis. A subgroup analysis of the REGAIN open-label extension study 18
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease 16
Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study 16
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report 14
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients 13
Clinical course of neurologic adverse events associated with immune checkpoint inhibitors focus on chronic toxicities 10
Clinical, histopathologic, and genetic features of patients with myofibrillary and distal myopathies 9
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies. An Italian Nationwide Survey 9
Upper body involvement in GNE myopathy assessed by muscle imaging 7
Clinical phenotype of pediatric and adult patients with spinal muscular atrophy with four SMN2 copies: are they really all stable? 6
null 4
Totale 5.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020669 0 0 0 0 0 107 146 107 132 70 69 38
2020/2021615 55 114 107 44 19 42 25 27 55 74 35 18
2021/2022849 63 35 94 44 108 43 33 89 36 39 150 115
2022/2023989 138 200 40 108 111 86 37 91 69 23 57 29
2023/2024987 37 83 54 61 59 123 65 125 30 135 97 118
2024/2025789 78 159 127 162 177 86 0 0 0 0 0 0
Totale 5.550